South Korea Trypsin Market Size, Share, and COVID-19 Impact Analysis, By Source (Bovine and Porcine), By Application (Biotechnology & Pharmaceutical Industry and Food Industry), By End-use (Research, Diagnostic, and Industrial Use), and South Korea Trypsin Market Insights, Industry Trend, Forecasts to 2035.

Industry: Healthcare

RELEASE DATE May 2025
REPORT ID SI10736
PAGES 190
REPORT FORMAT PathSoft

South Korea Trypsin Market Insights Forecasts to 2035

  • The South Korea Trypsin Market Size Was Estimated at USD 2.5 Million in 2024
  • The Market Size is Expected to Grow at a CAGR of around 8.12% from 2025 to 2035
  • The South Korea Trypsin Market Size is Expected to Reach USD 5.9 Million by 2035

 

South Korea Trypsin Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, The South Korea Trypsin Market Size is Anticipated to reach USD 5.9 Million By 2035, Growing at a CAGR of 8.12% from 2025 to 2035. Trypsin is a necessary enzyme for the digestion of proteins, and its increasing application in a variety of sectors, such as detergents, food science research, medicines, and leather-bating, is anticipated to support market growth. Further propelling market expansion is the increased focus on drug development and discovery.

 

Market Overview

The market for trypsin refers to the manufacture, distribution, and sale of trypsin, a pancreatic enzyme required for protein digestion. As a proteolytic enzyme, trypsin is a key enzyme in the pharmaceutical, biotechnology, research, and food processing industries. Its importance is particularly evident in the biopharmaceutical industry, where it has extensive application in the production of therapeutic proteins, vaccine production, manufacturing of biosimilars, peptide mapping, and cell culture processes. The rising need for biopharmaceuticals and regenerative medicine is a key market growth driver. Strict safety, quality, and efficacy requirements are imposed by regulatory agencies, which prolong the duration and raise the cost of developing and bringing new trypsin-based products to the market. In spite of these challenges, increased investments by governments in research and development, especially in drug discovery and diagnostic usage, are providing conducive conditions for market growth. Moreover, government-sponsored biotechnology research initiatives across the world are providing new avenues for firms involved in trypsin production and supply, making trypsin a critical ingredient in the coming pharmaceutical and life sciences industries.

 

Report Coverage

This research report categorizes the market for the South Korea trypsin market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea trypsin market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea trypsin market.

 

South Korea Trypsin Market Report Coverage

Report CoverageDetails
Base Year:2024
Market Size in 2024:USD 2.5 Million
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :8.12%
2035 Value Projection:USD 5.9 Million
Historical Data for:2020-2023
No. of Pages:190
Tables, Charts & Figures:104
Segments covered:By Source, By Application, By End-use and COVID-19 Impact Analysis
Companies covered:: Hyosung Chemical Corporation, Samsung Biologics, Lotte Biologics, Celltrion, SK Bioscience, Hanmi Pharm, Adipogen Inc., iNtRON Biotechnology, Koma Biotech, Nexgen Biotechnologies Inc., SolGent Co., Ltd., GenoFocus Inc., and other key vendors.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

Trypsin plays a vital role in cell culture, protein sequencing, and genetic engineering in the field of biotechnology. It is also employed in biopharmaceutical R&D, such as drug development and regenerative medicine. The spurt in monoclonal antibody (mAb) production and growth in recombinant protein therapies are key drivers. Increasing awareness and demand for enzyme-based treatments, especially for chronic diseases, are driving trypsin market growth. Trypsin is utilized in food processing for meat tenderization and clarification of beverages, enhancing product quality and sensory attraction. Rising demand for convenience foods and a move towards natural, enzyme-based products are also propelling this application.

 

Restraining Factors

The animal source trypsin is subject to contamination and prion disease-related concerns, prompting the use of more expensive recombinant forms by manufacturers. The high heat and organic solvent sensitivity of trypsin restrict its application in some instances. The industry is also under threat from other competing enzymes that have shown great catalytic potential and can serve as a substitute for trypsin.

 

Market Segmentation

The South Korea trypsin market share is classified into source, application, and end-use.

  • The bovine segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea trypsin market is segmented by source into bovine and porcine. Among these, the bovine segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Bovine trypsin's unique cleavage activity has led to its extensive application in a variety of disciplines. Bovine trypsin obtained from animals is frequently used in the manufacturing of vaccines and is essential for cell culture applications in research labs like Sisco Research Laboratories.

 

  • The biotechnology & pharmaceutical industry segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea trypsin market is segmented by application into biotechnology & pharmaceutical industry and food industry. Among these, the biotechnology & pharmaceutical industry segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The structure-function correlations in target proteins and aid in the development of new treatments, trypsin is frequently employed in high-throughput screening techniques to investigate protein interactions with possible drug candidates.

 

  • The industrial use segment held a largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea trypsin market is segmented by end-use into research, diagnostic, and industrial use. Among these, the industrial use segment held a largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growing use of trypsin in industries like food and medicine, detergents, and leather bating. Trypsin is used in detergents to remove protein-based stains such as blood and egg. However, due to safety and environmental concerns, its use in this industry is rather limited.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea trypsin market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Hyosung Chemical Corporation
  • Samsung Biologics
  • Lotte Biologics
  • Celltrion
  • SK Bioscience
  • Hanmi Pharm
  • Adipogen Inc.
  • iNtRON Biotechnology
  • Koma Biotech
  • Nexgen Biotechnologies Inc.
  • SolGent Co., Ltd.
  • GenoFocus Inc.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea trypsin market based on the below-mentioned segments

 

South Korea Trypsin Market, By Source

  • Bovine
  • Porcine

 

South Korea Trypsin Market, By Application

  •  Biotechnology & Pharmaceutical Industry
  •  Food Industry

 

South Korea Trypsin Market, By End-use

  • Research
  •  Diagnostic
  •  Industrial Use

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies